Bioactive Flavonoids and Phenolic Acids of Petroselinum crispum as a Potential Inhibitor of α-amylase: An In silico Evaluation

This finding suggests apigenin as alternative therapeutics in treating diabetes mellitus by targeting the enzyme α-amylase which can be used for in vitro cross-validation studies. This study is the first documentation of the antidiabetic potentiality of the flavonoid compounds of Petroselinum crispum through in silico investigation.